GR3021221T3 - Piperazine derivatives - Google Patents

Piperazine derivatives

Info

Publication number
GR3021221T3
GR3021221T3 GR960402575T GR960402575T GR3021221T3 GR 3021221 T3 GR3021221 T3 GR 3021221T3 GR 960402575 T GR960402575 T GR 960402575T GR 960402575 T GR960402575 T GR 960402575T GR 3021221 T3 GR3021221 T3 GR 3021221T3
Authority
GR
Greece
Prior art keywords
piperazine derivatives
rsqbstr
lsqbstr
phenylbutyryl
azepin
Prior art date
Application number
GR960402575T
Other languages
English (en)
Inventor
Ian Anthony Cliffe
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of GR3021221T3 publication Critical patent/GR3021221T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Indole Compounds (AREA)
GR960402575T 1990-10-19 1996-10-02 Piperazine derivatives GR3021221T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909022820A GB9022820D0 (en) 1990-10-19 1990-10-19 Piperazine derivatives

Publications (1)

Publication Number Publication Date
GR3021221T3 true GR3021221T3 (en) 1997-01-31

Family

ID=10684053

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402575T GR3021221T3 (en) 1990-10-19 1996-10-02 Piperazine derivatives

Country Status (15)

Country Link
EP (1) EP0481744B1 (el)
JP (1) JP3007203B2 (el)
KR (1) KR100193928B1 (el)
AT (1) ATE143012T1 (el)
AU (1) AU642044B2 (el)
CA (1) CA2053709C (el)
DE (1) DE69122205T2 (el)
DK (1) DK0481744T3 (el)
ES (1) ES2091879T3 (el)
GB (2) GB9022820D0 (el)
GR (1) GR3021221T3 (el)
HU (2) HU212943B (el)
IE (1) IE65379B1 (el)
NZ (1) NZ240271A (el)
PT (1) PT99251B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125900D0 (en) * 1991-12-05 1992-02-05 Wyeth John & Brother Ltd Piperazine derivatives
CA2141810A1 (en) * 1992-08-05 1994-02-17 Ian A. Cliffe Amide derivatives
GB9221931D0 (en) * 1992-10-17 1992-12-02 Wyeth John & Brother Ltd Piperazine derivatives
GB2271930B (en) * 1992-11-03 1996-07-24 Wyeth John & Brother Ltd Pharmaceutical piperazine derivatives
GB9223153D0 (en) * 1992-11-05 1992-12-16 Wyeth John & Brother Ltd Piperazine derivatives
GB9303968D0 (en) * 1993-02-26 1993-04-14 Wyeth John & Brother Ltd 5-ht1a ligands
GB9304632D0 (en) * 1993-03-06 1993-04-21 Wyeth John & Brother Ltd Amide derivatives
US5609849A (en) * 1994-03-11 1997-03-11 The Trustees Of The University Of Pennsylvania Serotonin (5-HT1A) receptor ligands and imaging agents
GB9419024D0 (en) * 1994-09-21 1994-11-09 Wyeth John & Brother Ltd Bicyclic carboxamides
GB9525239D0 (en) * 1995-12-09 1996-02-07 American Home Prod Medical treatment
FR2744448B1 (fr) * 1996-02-02 1998-04-24 Pf Medicament Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
ITMI20021327A1 (it) * 2002-06-14 2003-12-15 Recordati Chem Pharm Nuove ossialchilpiperazine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776282A (en) * 1954-05-04 1957-01-01 Searle & Co Cyclic amides of alpha-toluic acids and derivatives thereof
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
KR0173310B1 (ko) * 1989-04-22 1999-02-01 폴 에이 리쳐 피페라진 유도체
AU644488B2 (en) * 1990-10-19 1993-12-09 John Wyeth & Brother Limited Piperazine derivatives

Also Published As

Publication number Publication date
JPH04282371A (ja) 1992-10-07
DK0481744T3 (da) 1996-10-07
GB2248836A (en) 1992-04-22
IE65379B1 (en) 1995-10-18
PT99251B (pt) 1999-04-30
GB9022820D0 (en) 1990-12-05
KR920008019A (ko) 1992-05-27
GB2248836B (en) 1994-05-04
ATE143012T1 (de) 1996-10-15
KR100193928B1 (ko) 1999-06-15
CA2053709C (en) 2001-12-11
CA2053709A1 (en) 1992-04-20
HU913292D0 (en) 1992-01-28
EP0481744B1 (en) 1996-09-18
ES2091879T3 (es) 1996-11-16
GB9118744D0 (en) 1991-10-16
IE913669A1 (en) 1992-04-22
EP0481744A1 (en) 1992-04-22
AU642044B2 (en) 1993-10-07
PT99251A (pt) 1992-08-31
DE69122205D1 (de) 1996-10-24
HU211587A9 (en) 1995-12-28
JP3007203B2 (ja) 2000-02-07
DE69122205T2 (de) 1997-01-30
HU212943B (en) 1996-12-30
HUT60264A (en) 1992-08-28
AU8592091A (en) 1992-04-30
NZ240271A (en) 1993-03-26

Similar Documents

Publication Publication Date Title
GB2248836B (en) Piperazine derivatives
AU674477B2 (en) Heterocyclic-cyclic amine derivatives
OA09521A (en) Heterocyclic N-oxide derivatives of substituted benzo 5,6 cycloheptapyridines compositions and methods of use
IE823067L (en) Piperidinedione derivatives
SI0707007T1 (en) (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent
GR3020369T3 (en) Xanthine derivatives
CA2275987A1 (en) Acid addition salt of optically active piperidine compound and process for preparing the same
AU644051B2 (en) Piperidine derivatives
EP0276543A3 (en) Use of buspirone for the improvement of short term memory
NO903640D0 (no) Fremgangsmaate for fremstilling av 2-(rs)-substituerte 2,3-dihydro-5-oksy-4,6,7-trimetylbenzofuraner.
IE812069L (en) Azaspirodecanediones
NZ216750A (en) Morpholino derivatives and fungicides
HU9202914D0 (en) 4-(4-(4-hydroxiphenyl)-1-piperazinyl)-5-methyl-3h-1,2,4-triazole-3-one derivatives
ATE139523T1 (de) Neue verbindungen und deren medizinale verwendung
MY110446A (en) Piperazine derivatives
EP0333676A3 (en) Use of 1-(2-ethoxy-2-(3'-pyridyl)ethyl)-4-(2'methoxy-phenyl)piperazine, for the preparation of pharmaceutical compositions useful for the treatment of lower urinary tract disfunctions and benign prostatic hypertrophy
MX9201297A (es) Derivados piperacinicos y procedimiento para su preparacion.
ES2149691A1 (es) 2-4-[4-(4,5-dicloro-2metilimidazol-1-il)butil]-1-piperacinil -5-fluoropirimidina, su preparacion y su utilizacion terapeutica.
PL298827A1 (en) Novel enantiomers derivatives of (s)-2-amino(3,4-dichlorobenzyl) propanol-1
MX9604201A (es) Nuevos derivados de piperidina.